Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Net Margin (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) posted Net Margin of -49290.48% for FY2025 (year ended Jun 30, 2025).

Analysis

Kazia Therapeutics (KZIA) Net Margin (2009 - 2013) Analysis & Trends

Since FY2009, Kazia Therapeutics has reported Net Margin for 15 fiscal years.

  • Annual Net Margin shows a five-year change of -48115.45 percentage points (FY2020 to FY2025).
  • The FY2025 figure stands as the lowest annual Net Margin in data going back to FY2009.
  • Business Quant data shows KZIA's Net Margin at -1160.23% in FY2024 and -55.46% in FY2021 (+1119.57 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 0.83%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 24.24%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 28.01%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 20.69%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 37.28%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 29.27%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 19.55%
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -176.60%
Aug 30, 2013 -123.39%
Dec 31, 2012 20.12%
Dec 31, 2011 1,187.05%
Dec 31, 2010 890.52%
Jun 30, 2010 -4,982.35%
Dec 31, 2009 -1,004.52%
API Access

Kazia Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=KZIA&period=max&api_key=YOUR_API_KEY